PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Thursday-Friday, August 12–13. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Please join us for next month’s PrimaryCareNOW on Thursday–Saturday, September 9–11.

Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Upcoming Conferences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Endocrinology

Updates from American Diabetes Association 2021 

Martin J. Abrahamson, MD, FACP

 

This session will cover some new data regarding treatment of type 2 diabetes: the GRADE study, SURPASS phase 3 program, the STEP program for treatment of obesity. It will also provide an update on studies using SGLT2 inhibitors and GLP 1 receptor agonists in people with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease.

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA

9:10–10:10am ET    CME/CE Accredited Session

Psychiatry

 

Personality disorders are a class of mental disorders characterized by pervasive maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from cultural norms. These patterns are inflexible and are associated with distress and impairment. That said, the definitions are controversial. Case examples will illustrate this class of mental disorders, along with suggested non-pharmacological and pharmacological interventions. 

Shirah Vollmer, MD

Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA

10:20–11:05am ET    Non-CME Industry Theater

Neurology

An Oral CGRP Antagonist for the Acute Treatment of Migraine

Andrew Blumenfeld, MD

 

This product theater will focus on the commitment AbbVie has to migraine patients and discusses an oral CGRP receptor antagonist for the acute treatment of migraine.

Andrew Blumenfeld, MD

Director, Headache Center of Southern California

Sponsored by AbbVie

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Ryan D. Reber, DO

 

Join us to learn about a maintenance therapy for the treatment of COPD.

Ryan D. Reber, DO

Chief of Pulmonary and Critical Care Medicine, Medical Director, Intensive Care Unit, Paoli Hospital, Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University

Sponsored by Viatris & Theravance Biopharma

11:15am–12:15pm ET    CME/CE Accredited Session

Hepatology

 

Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.

Sammy Saab, MD, MPH, AGAF

Medical Director, Pfleger Liver Institute at UCLA, Medical Director, UCLA Adult Liver Transplant Program, Chief, UCLA Transplant Hepatology, Head, Outcomes Research in Hepatology at UCLA, Professor of Medicine and Surgery, UCLA, Adjunct Professor of Nursing, UCLA, Los Angeles, CA

12:25–1:25pm ET    CME/CE Accredited Session

Infectious Disease

Vaccination Matters: Understanding and Combating Hesitancy and Disparities in Vaccination

Robert H. Hopkins Jr., MD, FACP, FAAP | Gregory L. Hall, MD

 

Vaccination is a cornerstone of preventive medicine. However, many individuals fail to receive the benefits of vaccination due to growing vaccine hesitancy and a lack of effective communication about vaccines. This is especially troubling amidst the COVID-19 pandemic, as decisions to decline COVID-19 vaccination present not only increased risk to individuals but also an immediate and massive public health risk. This public health problem is magnified in already health-disparate communities, such as those of Black and Hispanic individuals, in the United States. In this session, Dr. Robert Hopkins and Dr. Gregory Hall will address these concerns by raising PCPs’ awareness of vaccine hesitancy and their understanding of how it affects diverse populations differently. The education will provide PCPs with concrete strategies, including culturally competent communication, to overcome vaccine hesitancy in patients from all backgrounds. 

Robert H. Hopkins Jr., MD, FACP, FAAP

Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH

Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP

1:35–2:20pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Brett Smith, DO

 

  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Brett Smith, DO

Sponsored by AbbVie

1:35–2:20pm ET    Non-CME Industry Theater

Cardiology

Ted Okerson, MD, FACP, FACE

 

  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).

  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial
 

Ted Okerson, MD, FACP, FACE

Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.

Sponsored by AstraZeneca Pharmaceuticals, LP

2:30–3:30pm ET    CME/CE Accredited Session

Hot Topics

 

Despite the array of products and minimal regulation, it is possible to find high quality dietary supplements and use them in a rational evidence-informed manner in the care of many primary care problems. Discussion goes beyond the management of so-called short latency deficiency syndromes taught in the past to current applications for a few common primary care problems such as anxiety, depression, emotional and physical exhaustion and insomnia. We will also identify those who may need adjuncts to their diet and useful databases to find more information.

Donald B. Levy, MD

Medical Director, Osher Clinical Center for Integrative Medicine, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston, MA

3:40–4:40pm ET    CME/CE Accredited Session

Geriatrics

Managing Patients with Cognitive Decline in Primary Care 

Katherine E. Galluzzi, DO, CMD, FACOFP

 

Primary care patients who present with cognitive change represent a clinical challenge. Delirium must be differentiated from dementia, as delirium represents a medical emergency. In this session, potential causes of delirium, Alzheimer disease and other leading causes of dementia will be reviewed. Faculty will outline the clinical findings, screening tools, diagnostic studies, and potential therapies for cognitive decline in the geriatric patient.  

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chairperson, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

4:50–5:35pm ET    Non-CME Industry Theater

Infectious Disease

Helping to Protect Your Older Adult Patients From the Impact of Influenza

Edward A. Dominguez, MD, FACP, FIDSA

 

  • Examine the medical burden of influenza disease in adults 50 years of age and older, including ways in which influenza can exacerbate chronic comorbid conditions and lead to severe health outcomes.
  • Review clinical evidence for 2 influenza vaccines shown to help protect older adults against influenza.

Edward A. Dominguez, MD, FACP, FIDSA

Medical Director, Organ Transplant Infectious Disease, Methodist Transplant Specialists

Sponsored by Sanofi Pasteur Inc.

8–9am ET    CME/CE Accredited Session

Endocrinology

 

Learn the latest on the diagnosis and treatment of postmenopausal osteoporosis, including the latest guidelines regarding initial choice of agents, as well as duration and sequential use of drugs. 

Pauline M. Camacho, MD, FACE

Professor of Medicine, Director of Loyola University Osteoporosis and Metabolic Bone Disease Center, Loyola University Medical Center

9:10–10:10am ET    CME/CE Accredited Session

Gastroenterology

"My Belly Hurts and I'm Having Bowel Problems": Stepping Up Treatment of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Philip Schoenfeld, MD, MSEd, MSc

 

This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals

10:20–11:05am ET    Non-CME Industry Theater

Gastroenterology

A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data

Gregory S. Sayuk, MD, MPH

 

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.

Gregory S. Sayuk, MD, MPH

Associate Professor of Medicine, Division of Gastroenterology, at Washington University School of Medicine, St. Louis, Missouri

Sponsored by AbbVie

10:20am–11:05pm ET    Non-CME Industry Theater

Pulmonology

Uncontrolled Asthma: Changing the Patient Experience

Matthew Mintz, MD, FACP

 

This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Matthew Mintz, MD, FACP

Associate Clinical Professor of Medicine, George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician,, Private Practice in Bethesda, Maryland

Sponsored by GlaxoSmithKline

11:15am–12:45pm ET    CME/CE Accredited Session

Neurology

Top Questions in Acute Head Issues: Stroke, Headache, and Dizziness/Vertigo 

Rashmi B. Halker Singh, MD, FAHS, FAAN | Galen V. Henderson, MD | Patricia E. Greenstein, MB.BCh

 

What do primary care providers need to know about acute head issues? Join expert faculty as they review important questions they get asked about these topics!

Rashmi B. Halker Singh, MD, FAHS, FAAN

Associate Professor of Neurology, Director, Headache Medicine Fellowship Program, Division of Headache Medicine, Department of Neurology, Mayo Clinic, Scottsdale, AZ

Galen V. Henderson, MD

Director, Division of Neurocritical Care Assistant, Professor of Neurology, Harvard Medical School, Boston, MA

Patricia E. Greenstein, MB.BCh

Assistant Professor, Harvard Medical School, Associate Director, BIDMC Neurology Residency Training Program, Director, Neurogenetics Clinic, Beth Israel Deaconess Medical Center, Boston, MA

12:55–1:40pm ET    Non-CME Industry Theater

Gastroenterology

Liver Disease Evaluation in Primary Care: Including Alpha-1 in Differential Diagnosis

Rajani Sharma, MD, MSc

 

This educational program will provide a practical overview of common liver diseases which may be encountered in Primary Care, such as NAFLD and NASH. Differentiation of less common hepatic pathology, such as alpha-1 antitrypsin deficiency, will be reviewed. 

Rajani Sharma, MD, MSc

Assistant Professor of Medicine, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, New York Presbyterian Hospital

Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

12:55–1:40pm ET    Non-CME Industry Theater

Cardiology

The Continuum of Heart Failure

Jonathan D. Rich, MD, FACC, FHFSA

 

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.

Jonathan D. Rich, MD, FACC, FHFSA

Associate Professor of Medicine, Northwestern University, Feinberg School of Medicine, Medical Director, Mechanical Circulatory Support Program, Program Director, Advanced Heart Failure and Transplant Fellowship, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, Illinois

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC 

1:50–2:50pm ET    CME/CE Accredited Session

Gastroenterology

Optimizing the Management of Iron Deficiency and Iron Deficiency Anemia in Inflammatory Bowel Disease: An Update for the Primary Care Provider

Neilanjan Nandi, MD, FACP

 

This session reviews the latest evidence-based data regarding iron deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD) and offers practical clinical insight into the diagnosis and management of this condition. Using a case-based approach, the presenting gastroenterologist discusses the multiple factors contributing to IDA in the IBD population and shares practical strategies for coordinating care across disciplines to recognize and effectively manage patients with this common condition. The current evidence base for using oral and intravenous iron therapies effectively in practice will also be reviewed. These practical pearls and pitfalls are intended to help optimize the care of IDA in patients with IBD seen in the primary care setting.  

Neilanjan Nandi, MD, FACP

Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA

Supported by American Regent, Inc.

3–4pm ET    CME/CE Accredited Session

LGBTQ Health

LGBTQ+ Mental Health in Primary Care 

Petros Levounis, MD, MA

 

It’s time for a down-to-earth, informative, and affirming discussion on LGBTQ+ mental health for primary care clinicians working with patients of diverse gender and sexual identities. In recent years, people have addressed these issues in a healthier, more public way, and all practitioners must be prepared to meet their patients with the knowledge, understanding, and grasp of cultural context of LGBTQ+ communities.

Petros Levounis, MD, MA

Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical School, Chief of Service, University Hospital, Newark, NJ

4:10–4:55pm ET    Non-CME Industry Theater

Urology

A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency

David R. Staskin, MD

 

In this session, we will discuss the clinical impact and physiology of overactive bladder as well as the latest perspectives on management and treatment. 

David R. Staskin, MD

Attending in Urology, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA

Sponsored by Astellas Pharma U.S., Inc.